Cargando…
Protection of protease-activated receptor 2 mediated vasodilatation against angiotensin II-induced vascular dysfunction in mice
BACKGROUND: Under conditions of cardiovascular dysfunction, protease-activated receptor 2 (PAR2) agonists maintain vasodilatation activity, which has been attributed to increased cyclooxygenase-2, nitric oxide synthase and calcium-activated potassium channel (SK3.1) activities. Protease-activated re...
Autores principales: | Chia, Elizabeth, Kagota, Satomi, Wijekoon, Enoka P, McGuire, John J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3192660/ https://www.ncbi.nlm.nih.gov/pubmed/21955547 http://dx.doi.org/10.1186/1471-2210-11-10 |
Ejemplares similares
-
Preserved arterial vasodilatation via endothelial protease-activated receptor-2 in obese type 2 diabetic mice
por: Kagota, Satomi, et al.
Publicado: (2011) -
Characterization and Functions of Protease-Activated Receptor 2 in Obesity, Diabetes, and Metabolic Syndrome: A Systematic Review
por: Kagota, Satomi, et al.
Publicado: (2016) -
Modulation of Vasomotor Function by Perivascular Adipose Tissue of Renal Artery Depends on Severity of Arterial Dysfunction to Nitric Oxide and Severity of Metabolic Parameters
por: Kagota, Satomi, et al.
Publicado: (2022) -
Migraine pain: reflections against vasodilatation
por: Panconesi, Alessandro, et al.
Publicado: (2009) -
Localized Vasodilatation
Publicado: (1933)